Cellular Dynamics International Priced, Nasdaq: ICEL
Develops and manufactures functioning human cells in large quantities.
Industry: Health Care
First Day Return: -20.8%
ICEL
Develops and manufactures functioning human cells in large quantities.
| IPO Data | |
|---|---|
| IPO Date | 07/24/2013 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $46 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Madison, WI, United States |
| Founded | 2004 |
| Employees at IPO | 115 |
| Website www.cellulardynamics.com | |
IPO News for Cellular Dynamics International
Cellular Dynamics International (ICEL) Performance
